Ten years after scrapping its controversial one-child policy, China’s policymakers are scrambling to reverse the country’s ...
Health‑advertising researcher Erin Willis at the University of Colorado-Boulder said consumers are now bombarded with GLP-1 ...
The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
San Francisco police are thanking their Honda Unit investigators for making a large narcotics bust in which officers recovered 193.5 grams of suspected MDMA/Ecstasy ...
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...
Eli Lilly is pursuing its own oral version of its obesity drug Zepbound. The Indiana-based company operates two new campuses in North Carolina — in Research Triangle Park and outside of Charlotte in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback